2016 American Transplant Congress
Impact of the New Kidney Allocation System on Highly Sensitized Patients: Single Center Report.
Background: Highly sensitized patients (HSP) with calculated Panel Reactive Antibody (cPRA) >80% are known to have extensive waiting time on UNOS list. The new kidney…2016 American Transplant Congress
The Simplified EPTS Score: Who Wins and Who Loses?
Cleveland Clinic, Cleveland, OH.
The New Kidney Allocation System includes provisions that candidates with EPTS score in the lowest 20% (indicating best expected survival) have access to the highest…2016 American Transplant Congress
Activating Transcription Factor 5 (ATF5) Regulates Liver Ischemia/Reperfusion Injury.
Activating transcription factor 5 (ATF5), a member of the ATF/cAMP response element-binding proteins, is extremely highly expressed in the liver, the significance of which is…2016 American Transplant Congress
Activation of Innate Immunity During Human OLT-IRI Triggers Adaptive Immunity and Correlates with the Degree of IRI Injury.
1Surgery, Dumont-UCLA Transplant Ctr, Los Angeles, CA; 2Pathology, UCLA, Los Angeles, CA.
Ischemia reperfusion injury (IRI) in orthotopic liver transplantation (OLT) can severely compromise graft and recipient survival. We postulate this is mediated by interactions between the…2016 American Transplant Congress
The Impact of Pre-Donation eGFR on Recipient Outcomes, as a Function of Donor Age.
1Medicine, UBC, Vancouver, BC, Canada; 2BC Renal Agency, Vancouver, BC, Canada.
Transplantation from older living kidney donors is increasing. Studies have shown that living donor age only modestly impacts recipient outcomes, but the kidney function of…2016 American Transplant Congress
Can Qrisk Be Useful to Predict Future Cardiovascular Co-Morbidites and Type II Diabetes in Living Kidney Donors Prior to Donation?
Department of Renal & Transplant Medicine, Manchester Royal Infirmary, Manchester, United Kingdom.
Introduction:Living kidney donor transplantation has demonstrated significant survival benefits to individuals with End Stage Renal Disease (ESRD). However, The long term cardiovascular risks associated with…2016 American Transplant Congress
Urinary Neutrophil Gelatinase-Associated Lipocalin in Living Kidney Donor Nephrectomy.
Introduction: Urinary neutrophil gelatinase-associated lipocalin (uNGAL) is a marker for acute kidney injury. This study was conducted to evaluate the efficacy of perioperative uNGAL in…2016 American Transplant Congress
Controlled Cardiac Death Donor Program for Kidney Transplantation – Spanish Multicenter Experience with Two Years of Follow-Up.
Background: Controlled donation after cardiac death (cDCD) programs are running in several countries for years. National transplant organization (ONT) has developed a nation-wide program in…2016 American Transplant Congress
Tumor-Necrosis-Factor-α Antagonist Therapy for Inflammatory Bowel Disease After Liver Transplantation.
Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI.
Background:The safety and effectiveness of tumor-necrosis-factor-α antagonist (anti-TNF-α) therapy for inflammatory bowel disease (IBD) has not been well-established in patients after liver transplantation (LT). We…2016 American Transplant Congress
Japanese Multicenter Study of Hepatopulmonary Syndrome in Living Donor Liver Transplantation.
Surgery, Tokyo Women's Medical University, Tokyo, Japan.
It is well known that hepatopulmonary syndrome (HPS) manifested with hypo-oxygenemia secondary to intra-pulmonary shunt has negative impacts on outcomes of liver transplantation in deceased…
- « Previous Page
- 1
- …
- 150
- 151
- 152
- 153
- 154
- …
- 180
- Next Page »